These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26268329)
1. Anti-Alzheimer Therapeutic Drugs Targeting γ-Secretase. Tan Y; Zhang Q; Wong SG; Hua Q Curr Top Med Chem; 2016; 16(5):549-57. PubMed ID: 26268329 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of gamma-secretase inhibitors and modulators. Imbimbo BP Curr Top Med Chem; 2008; 8(1):54-61. PubMed ID: 18220933 [TBL] [Abstract][Full Text] [Related]
3. Development and mechanism of γ-secretase modulators for Alzheimer's disease. Crump CJ; Johnson DS; Li YM Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767 [TBL] [Abstract][Full Text] [Related]
4. Advances in gamma-secretase modulation. Pissarnitski D Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480 [TBL] [Abstract][Full Text] [Related]
5. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246 [TBL] [Abstract][Full Text] [Related]
6. γ-Secretase as a target for Alzheimer's disease. Wolfe MS Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746 [TBL] [Abstract][Full Text] [Related]
7. Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A Curr Med Chem; 2011; 18(35):5430-47. PubMed ID: 22087836 [TBL] [Abstract][Full Text] [Related]
8. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates. McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895 [TBL] [Abstract][Full Text] [Related]
9. γ-Secretase modulator in Alzheimer's disease: shifting the end. Xia W; Wong ST; Hanlon E; Morin P J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916 [TBL] [Abstract][Full Text] [Related]
10. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891 [TBL] [Abstract][Full Text] [Related]
11. γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes. Imbimbo BP; Giardina GA Curr Top Med Chem; 2011; 11(12):1555-70. PubMed ID: 21510832 [TBL] [Abstract][Full Text] [Related]
12. γ-Secretase and its modulators: Twenty years and beyond. Xia W Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650 [TBL] [Abstract][Full Text] [Related]